Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Hair graying is caused by the loss of pigment cells due to poor maintenance of stem cells in the hair follicle.

The combined therapy significantly increased hair density and was safe for treating hair loss.

Finasteride worsens heart damage from nandrolone decanoate but protects against cell damage.

The hair follicle dermal sheath is essential for hair shedding and needs to communicate with the outer root sheath for normal hair growth cycles.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Liposomal curcumin improves skin cancer treatment effectiveness while sparing normal cells.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Finasteride and minoxidil together work best for male hair loss.